The European Union just banned a common gel nail polish ingredient, calling it "carcinogenic, mutagenic or toxic for reproduction."
Why it matters: TPO, short for trimethylbenzoyl diphenylphosphine oxide, remains legal in the U.S. — but the news is stirring concern at nail salons across the country.
A presidential commission on chronic childhood illness on Tuesday recommended revamping the country's vaccine injury program and requiring more advance approvals for childhood ADHD medications.
It stopped short of calling for a crackdown on pesticides and other chemicals used in farming.
Why it matters: The 20-page document from the Make America Healthy Again Commission tries to thread a needle by addressing major concerns of Health Secretary Robert F. Kennedy Jr.'s base without harming powerful agribusiness interests.
Graduating high school seniors are less adept at reading and math than before the pandemic, according to a national education report released Tuesday.
Why it matters: The data is the latest evidence students are still struggling to recover from COVID-era learning loss and comes as the Trump administration wants to dismantle the Education Department.
The Trump administration is trying to minimize possible political blowback if Congress doesn't extend enhanced Affordable Care Act subsidies by making it easier for people to get coverage that protects against high medical expenses in the event of serious illness or injury.
Why it matters: Strategists who've worked with President Trump see the expiration of broadened ACA subsidies and prospect of steep premium hikes as one of Republicans' biggest liabilities headed into the midterm elections.
Loved the different, more optimistic mindset. But what can I personally do to make a bigger, better difference?
Why it matters: The things college kids can do are the same things that all of us of any age can do to think, see and act more optimistically and optimally. I took a crack at 8 things you can do, starting today:
Hundreds of thousands of poor Americans are poised to get their disability benefits cut, as the Trump administration moves to reverse a Biden-era change.
Why it matters: It would hurt low-income and disabled Americans at a time when inflation is driving up the cost of food and shelter; and further cuts to Medicaid and food benefits are on tap.
A surge of recent licensing deals for Chinese drugs is sending new signals that the U.S. could be toppled as the world's biotech leader.
Why it matters: A decade-long national strategy to develop its biopharmaceutical industry has left China in a position to deliver medical products faster and cheaper.
